Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators. Astrup A, et al. Among authors: finer n. Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Int J Obes (Lond). 2012. PMID: 21844879 Free PMC article. Clinical Trial.
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance.
Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rössner S, Saris W, Van Gaal L, James W, Goulder M; STORM Study Group. Hansen D, et al. Among authors: finer n. Int J Obes Relat Metab Disord. 2001 Apr;25(4):496-501. doi: 10.1038/sj.ijo.0801481. Int J Obes Relat Metab Disord. 2001. PMID: 11319653 Clinical Trial.
Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rössner S, Lawrence E, Fletcher C, McCamish M; Author Group. Zelissen PM, et al. Among authors: finer n. Diabetes Obes Metab. 2005 Nov;7(6):755-61. doi: 10.1111/j.1463-1326.2005.00468.x. Diabetes Obes Metab. 2005. PMID: 16219020 Clinical Trial.
Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.
Seimon RV, Espinoza D, Finer N, James WP, Legler UF, Coutinho W, Sharma AM, Van Gaal L, Maggioni AP, Sweeting A, Torp-Pedersen C, Gebski V, Caterson ID. Seimon RV, et al. Among authors: finer n. Int J Obes (Lond). 2015 May;39(5):849-57. doi: 10.1038/ijo.2014.211. Epub 2014 Dec 18. Int J Obes (Lond). 2015. PMID: 25520249 Clinical Trial.
Obesity in Europe - does anybody care?
Astrup A, Rössner S, Finer N, Van Gaal L. Astrup A, et al. Among authors: finer n. Expert Opin Pharmacother. 2013 Jun;14(8):971-3. doi: 10.1517/14656566.2013.783016. Epub 2013 Mar 22. Expert Opin Pharmacother. 2013. PMID: 23517073 No abstract available.
573 results